Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Insurance Portability and Accountability Act | 1 | 2016 | 23 | 0.550 |
Why?
|
| Databases, Genetic | 4 | 2012 | 745 | 0.540 |
Why?
|
| Research Personnel | 1 | 2016 | 156 | 0.490 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2016 | 674 | 0.450 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 672 | 0.430 |
Why?
|
| Data Mining | 1 | 2012 | 88 | 0.420 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 884 | 0.390 |
Why?
|
| Carcinoma, Ductal, Breast | 5 | 2018 | 1216 | 0.370 |
Why?
|
| Databases as Topic | 1 | 2010 | 133 | 0.360 |
Why?
|
| Biological Specimen Banks | 1 | 2010 | 76 | 0.360 |
Why?
|
| Carcinoma in Situ | 4 | 2016 | 487 | 0.340 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 677 | 0.320 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 622 | 0.300 |
Why?
|
| Models, Biological | 5 | 2012 | 3254 | 0.280 |
Why?
|
| Breast Neoplasms | 11 | 2018 | 15694 | 0.270 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 2508 | 0.260 |
Why?
|
| Mastectomy | 2 | 2011 | 1534 | 0.250 |
Why?
|
| Algorithms | 3 | 2012 | 3890 | 0.240 |
Why?
|
| Database Management Systems | 1 | 2002 | 63 | 0.210 |
Why?
|
| Information Storage and Retrieval | 1 | 2002 | 135 | 0.200 |
Why?
|
| COP9 Signalosome Complex | 1 | 2019 | 72 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8873 | 0.180 |
Why?
|
| Neoplasms | 4 | 2014 | 15193 | 0.170 |
Why?
|
| Halobacterium | 5 | 1981 | 6 | 0.170 |
Why?
|
| Oncogenes | 1 | 2002 | 673 | 0.170 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 256 | 0.150 |
Why?
|
| Bacteriorhodopsins | 4 | 1980 | 9 | 0.150 |
Why?
|
| Internet | 3 | 2008 | 706 | 0.140 |
Why?
|
| Clonal Evolution | 1 | 2018 | 253 | 0.140 |
Why?
|
| Carotenoids | 4 | 1980 | 96 | 0.130 |
Why?
|
| Ki-67 Antigen | 4 | 2011 | 666 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2001 | 1152 | 0.130 |
Why?
|
| Genome | 2 | 2013 | 672 | 0.130 |
Why?
|
| Medical Informatics | 2 | 2010 | 198 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2012 | 11965 | 0.120 |
Why?
|
| Pseudogenes | 1 | 2014 | 81 | 0.120 |
Why?
|
| Gene Expression Profiling | 6 | 2013 | 5159 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1265 | 0.110 |
Why?
|
| Mutation | 2 | 2018 | 15179 | 0.110 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 7548 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2011 | 1053 | 0.100 |
Why?
|
| Diffusion | 1 | 2011 | 88 | 0.100 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 42 | 0.090 |
Why?
|
| Mitotic Index | 1 | 2011 | 162 | 0.090 |
Why?
|
| Organizational Innovation | 1 | 2010 | 68 | 0.090 |
Why?
|
| Computers, Molecular | 1 | 2009 | 1 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2011 | 471 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 1215 | 0.090 |
Why?
|
| Humans | 24 | 2019 | 261506 | 0.090 |
Why?
|
| Medical Record Linkage | 1 | 2008 | 32 | 0.080 |
Why?
|
| Tissue Banks | 1 | 2008 | 55 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2016 | 806 | 0.080 |
Why?
|
| Computational Biology | 2 | 2012 | 1271 | 0.080 |
Why?
|
| Biomarkers, Tumor | 5 | 2014 | 10331 | 0.080 |
Why?
|
| Mammography | 2 | 2012 | 1010 | 0.080 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2008 | 45 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 318 | 0.080 |
Why?
|
| Genomics | 2 | 2016 | 2738 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2009 | 785 | 0.080 |
Why?
|
| Lung Neoplasms | 5 | 2011 | 11538 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2011 | 1529 | 0.070 |
Why?
|
| Decision Trees | 1 | 2007 | 178 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1999 | 2341 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 600 | 0.070 |
Why?
|
| Receptor, ErbB-2 | 3 | 2011 | 2518 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2019 | 2947 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2008 | 272 | 0.070 |
Why?
|
| Adenocarcinoma | 3 | 2005 | 7789 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5178 | 0.070 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 634 | 0.060 |
Why?
|
| Mice | 4 | 2019 | 34495 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2011 | 1987 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2011 | 992 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1516 | 0.060 |
Why?
|
| Artificial Intelligence | 2 | 2007 | 388 | 0.060 |
Why?
|
| Phenotype | 2 | 2012 | 6295 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1960 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2019 | 7226 | 0.060 |
Why?
|
| Patient Selection | 1 | 2011 | 2055 | 0.060 |
Why?
|
| Software | 1 | 2010 | 1321 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 1999 | 4638 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2002 | 71 | 0.050 |
Why?
|
| Female | 13 | 2019 | 141928 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 6009 | 0.050 |
Why?
|
| Water Microbiology | 1 | 1981 | 22 | 0.050 |
Why?
|
| Community Health Services | 1 | 2003 | 126 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2003 | 699 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2008 | 2218 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 1058 | 0.050 |
Why?
|
| Time Factors | 3 | 2011 | 12926 | 0.050 |
Why?
|
| Hydrochloric Acid | 1 | 1980 | 19 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 487 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 4744 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2003 | 533 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 664 | 0.040 |
Why?
|
| Apoptosis | 2 | 2011 | 7591 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 5539 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 2359 | 0.040 |
Why?
|
| Necrosis | 2 | 2012 | 580 | 0.040 |
Why?
|
| Hematuria | 1 | 1999 | 85 | 0.040 |
Why?
|
| United States | 1 | 2016 | 15433 | 0.040 |
Why?
|
| Cytodiagnosis | 1 | 1999 | 220 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 1130 | 0.040 |
Why?
|
| Disease Progression | 3 | 2016 | 6682 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 2450 | 0.040 |
Why?
|
| Hydroxycholesterols | 1 | 1996 | 16 | 0.040 |
Why?
|
| Gene Expression | 3 | 2014 | 3570 | 0.040 |
Why?
|
| Kinetics | 5 | 1996 | 2049 | 0.040 |
Why?
|
| Carcinoma | 1 | 2008 | 2578 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2003 | 1818 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2003 | 5319 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3981 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2012 | 1008 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1980 | 585 | 0.030 |
Why?
|
| Prognosis | 5 | 2019 | 21713 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2003 | 2819 | 0.030 |
Why?
|
| Animals | 6 | 2019 | 59536 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 470 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2010 | 731 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2011 | 1392 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2007 | 869 | 0.030 |
Why?
|
| Cholesterol | 1 | 1996 | 658 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 324 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2011 | 2086 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1239 | 0.030 |
Why?
|
| Cisplatin | 1 | 2019 | 2432 | 0.030 |
Why?
|
| Middle Aged | 5 | 2019 | 86204 | 0.030 |
Why?
|
| Cell Size | 1 | 2012 | 136 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2012 | 138 | 0.030 |
Why?
|
| Photolysis | 3 | 1980 | 14 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 311 | 0.020 |
Why?
|
| Genomic Structural Variation | 1 | 2011 | 77 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3821 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2011 | 37905 | 0.020 |
Why?
|
| Macrophages | 1 | 1996 | 1304 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 2483 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 2466 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 14551 | 0.020 |
Why?
|
| Calcinosis | 1 | 2012 | 423 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 216 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2008 | 181 | 0.020 |
Why?
|
| Texas | 2 | 2008 | 6311 | 0.020 |
Why?
|
| Keratins | 1 | 2008 | 330 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2011 | 1021 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 671 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 598 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 14289 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 479 | 0.020 |
Why?
|
| Actins | 1 | 2008 | 608 | 0.020 |
Why?
|
| Actinin | 1 | 2003 | 21 | 0.010 |
Why?
|
| Spectrophotometry | 2 | 1980 | 82 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 3552 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 509 | 0.010 |
Why?
|
| Aged | 3 | 2018 | 70117 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 4988 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 3045 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 77950 | 0.010 |
Why?
|
| Cell Line | 2 | 2003 | 5114 | 0.010 |
Why?
|
| Ecology | 1 | 1981 | 13 | 0.010 |
Why?
|
| Melanoma | 1 | 1999 | 5317 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6207 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1981 | 196 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 842 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1981 | 156 | 0.010 |
Why?
|
| Magnesium | 1 | 1981 | 160 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 1980 | 16 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2003 | 829 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2003 | 584 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 4892 | 0.010 |
Why?
|
| Temperature | 2 | 1978 | 506 | 0.010 |
Why?
|
| Photosynthesis | 1 | 1979 | 13 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2008 | 2295 | 0.010 |
Why?
|
| Water | 1 | 1981 | 361 | 0.010 |
Why?
|
| Salts | 1 | 1978 | 11 | 0.010 |
Why?
|
| Light | 1 | 1979 | 245 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 1013 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 2074 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1978 | 139 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2084 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 5437 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 15862 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 1996 | 66 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 13658 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1978 | 1258 | 0.010 |
Why?
|
| Biological Transport | 1 | 1996 | 597 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 5112 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 9180 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 10035 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 4849 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4053 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 29902 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 9244 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 32848 | 0.000 |
Why?
|
| Chemistry | 1 | 1978 | 99 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1978 | 137 | 0.000 |
Why?
|